Skip to main content
Figure 1 | BMC Pulmonary Medicine

Figure 1

From: Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy

Figure 1

Available data of 6MWD for each patient at different time points e.g. start of iloprost (BL-ilo), 3 months (3 Mo) and 12 months (12 Mo) after iloprost initiation. The median of the 6MWD increased from BL-ilo to 3 Mo and 12 Mo (289 m vs. 298 m vs. 345 m). However, the between group differences were not statistical significant (one-way ANOVA: p = 0.09)

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us